X-106900812-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_138382.3(RIPPLY1):c.393C>T(p.Tyr131=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000829 in 1,209,537 control chromosomes in the GnomAD database, including 5 homozygotes. There are 258 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 2 hom., 128 hem., cov: 23)
Exomes 𝑓: 0.00047 ( 3 hom. 130 hem. )
Consequence
RIPPLY1
NM_138382.3 synonymous
NM_138382.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.993
Genes affected
RIPPLY1 (HGNC:25117): (ripply transcriptional repressor 1) This gene encodes a protein similar to a zebrafish protein which acts as a transcriptional repressor in and is required for somite segmentation in zebrafish embryos (PMID: 16326386). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
CLDN2 (HGNC:2041): (claudin 2) This gene product belongs to the claudin protein family whose members have been identified as major integral membrane proteins localized exclusively at tight junctions. Claudins are expressed in an organ-specific manner and regulate tissue-specific physiologic properties of tight junctions. This protein is expressed in the intestine. Alternatively spliced transcript variants with different 5' untranslated region have been found for this gene.[provided by RefSeq, Jan 2010]
MORC4 (HGNC:23485): (MORC family CW-type zinc finger 4) In human, the four current members of the microrchidia (morc) gene family share an N-terminal ATPase-like ATP-binding region and a CW four-cysteine zinc-finger motif. The protein encoded by this gene also has a nuclear matrix binding domain and a two-stranded coiled-coil motif near its C-terminus. This gene is widely expressed at low levels in normal tissues and has elevated expression in placenta and testis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant X-106900812-G-A is Benign according to our data. Variant chrX-106900812-G-A is described in ClinVar as [Benign]. Clinvar id is 786709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.993 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.000472 (518/1097875) while in subpopulation AFR AF= 0.0173 (456/26401). AF 95% confidence interval is 0.016. There are 3 homozygotes in gnomad4_exome. There are 130 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIPPLY1 | NM_138382.3 | c.393C>T | p.Tyr131= | synonymous_variant | 4/4 | ENST00000276173.5 | |
RIPPLY1 | NM_001171706.2 | c.252C>T | p.Tyr84= | synonymous_variant | 2/2 | ||
CLDN2 | NM_001171092.1 | c.-179+308G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIPPLY1 | ENST00000276173.5 | c.393C>T | p.Tyr131= | synonymous_variant | 4/4 | 1 | NM_138382.3 | P1 | |
RIPPLY1 | ENST00000411805.1 | c.252C>T | p.Tyr84= | synonymous_variant | 2/2 | 1 | |||
CLDN2 | ENST00000541806.6 | c.-179+308G>A | intron_variant | 1 | P1 | ||||
MORC4 | ENST00000604604.1 | c.112-85026C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00435 AC: 485AN: 111609Hom.: 2 Cov.: 23 AF XY: 0.00378 AC XY: 128AN XY: 33833
GnomAD3 genomes
AF:
AC:
485
AN:
111609
Hom.:
Cov.:
23
AF XY:
AC XY:
128
AN XY:
33833
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00114 AC: 207AN: 181027Hom.: 1 AF XY: 0.000864 AC XY: 58AN XY: 67143
GnomAD3 exomes
AF:
AC:
207
AN:
181027
Hom.:
AF XY:
AC XY:
58
AN XY:
67143
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000472 AC: 518AN: 1097875Hom.: 3 Cov.: 30 AF XY: 0.000358 AC XY: 130AN XY: 363307
GnomAD4 exome
AF:
AC:
518
AN:
1097875
Hom.:
Cov.:
30
AF XY:
AC XY:
130
AN XY:
363307
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00434 AC: 485AN: 111662Hom.: 2 Cov.: 23 AF XY: 0.00378 AC XY: 128AN XY: 33896
GnomAD4 genome
AF:
AC:
485
AN:
111662
Hom.:
Cov.:
23
AF XY:
AC XY:
128
AN XY:
33896
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at